INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International
INVO Fertility announced that its Wisconsin Fertility Institute presented five poster abstracts at the 2026 Midwest Reproductive Symposium International, focusing on the efficacy of platelet-rich plasma (PRP) in treating poor IVF outcomes. The retrospective studies, involving patient cohorts ranging from 9 to 19 individuals, reported improvements in ovarian response, embryo development, and endometrial thickness, with mean thickness increasing from 6.1 mm to 8.1 mm in one cohort.
Key figures
- Study 1 patients
- 19
- Study 2 patients
- 19
- Study 3 patients
- 17
- Study 4 patients
- 9
- Study 5 patients
- 9
- Mean endometrial thickness pre
- 6.1
- Mean endometrial thickness post
- 8.1
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.